Shares of Applied DNA Sciences, Inc. (APDN) are up more than 8% in the morning trade on Monday after the company announced its COVID-19 diagnostic strategy in the wake of emergence of the new Coronavirus variant, Omicron.
The company said it plans to introduce its Linea 2.0 COVID-19 Assay, a new RT-PCR assay for the SARS-CoV-2 E and N genes, after submission of its validation data in the next few days to the New York State Department of Health (NYSDOH).
APDN, currently at $5.79, has been trading in the range of $4.65- $13.64 in the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.